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Abstract The objective of this study is to determine if
quality of care, symptoms of depression, disease charac-
teristics and quality of life of patients with amyotrophic
lateral sclerosis (ALS) are related to requesting euthanasia
or physician-assisted suicide (EAS) and dying due to EAS.
Therefore, 102 ALS patients filled out structured ques-
tionnaires every 3 months until death and the results were
correlated with EAS. Thirty-one percent of the patients
requested EAS, 69 % of whom eventually died as a result
of EAS (22 % of all patients). Ten percent died during
continuous deep sedation; only one of them had explicitly
requested death to be hastened. Of the patients who
requested EAS, 86 % considered the health care to be good
or excellent, 16 % felt depressed, 45 % experienced loss of
dignity and 42 % feared choking. These percentages do not
differ from the number of patients who did not explicitly
request EAS. The frequency of consultations of profes-
sional caregivers and availability of appliances was similar
in both groups. Our findings do not support continuous
deep sedation being used as a substitute for EAS. In this
prospective study, no evidence was found for a relation
between EAS and the quality and quantity of care received,
quality of life and symptoms of depression in patients with
ALS. Our study does not support the notion that unmet
palliative care needs are related to EAS.
Keywords Depression  Euthanasia  Physician-assisted
death  Palliative care
Introduction
The majority of the patients who request EAS have cancer
[22]. Patients with amyotrophic lateral sclerosis (ALS),
however, are a well-known and frequently used example in
case studies [2] and television broadcasts on euthanasia.
ALS is characterized by progressive degeneration of motor
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neurons and the clinical hallmarks are progressive limb
weakness, respiratory failure and bulbar palsy [19]. The
majority of patients die within 5 years after onset of the
disease, usually due to respiratory insufficiency [6].
Since there is no cure for ALS; specialized palliative
care is the best treatment available [20]. We examined
retrospectively the actual end-of-life practices performed in
patients with ALS over the periods 1994–1998 [32] and
2000–2005 [15] and found that 20 % died as a result of
EAS, a percentage which was said to be unacceptably high
[7]. In relation to this, the quality and availability of pal-
liative care in The Netherlands has been questioned [16]. It
is suggested that identifying patients with a wish for EAS
early on in the course of their illness will enable an inter-
vention and that intensive palliative treatment will reduce
the interest in euthanasia [7].
In view of these grave concerns and the relatively high
proportion of EAS in ALS patients in The Netherlands, we
performed a prospective study on factors that may influ-
ence the attitude towards EAS and a final decision for EAS
in ALS patients. The objective of this study is to determine
if quality of care, depression, quality of life, coping style,
and characteristics of the disease of ALS patients are
related to requesting EAS and dying as a result of EAS.
Methods
Study design
Participating patients completed questionnaires every
3 months until death. The follow-up consisted of a selec-
tion of the questionnaires that were used at baseline. The
follow-up questionnaires that were completed closest to the
patient’s death were used for the analyses. When the
patient died, the treating physician filled in a questionnaire
in which end-of-life practices and received requests were
documented.
All physician questionnaires were self-administered.
The patients self-administered all except three question-
naires (ALSFRS-r, CIDI, MMSE). If the patient was
physically unable to fill in a questionnaire that was sup-
posed to be self-administered, a trained interviewer helped
the patient complete all the questionnaires at home.
Participants
One hundred and ninety-two ALS patients were selected
through the three national referral centers for amyotrophic
lateral sclerosis (University medical center of Utrecht,
University medical center of Amsterdam, the Radboud
university medical center of Nijmegen). All patients were
diagnosed with probable or definite ALS [3], understood
the Dutch language, could communicate at least ‘‘yes’’ and
‘‘no’’, were not dependent on tracheotomy with mechanical
ventilation, did not have a severe cognitive impairment,
had no clinical diagnosis of frontotemporal dementia, had a
life expectancy of 6 months or less and ultimately died
during the study. Life expectancy estimates were based on
clinical appraisal by a neurologist specialized in ALS and a
forced vital capacity of less than 60 % [18]. One hundred
and thirty-six (71 %) of the 192 selected patients agreed to
participate. Seventeen of these patients left the study early,
because they felt too tired. Three patients developed severe
cognitive impairment and fourteen patients survived the
period until closure of the study and were, therefore,
excluded. All included patients (n = 102) died from
October 2003 to March 2008. The 56 non-responders and
the 34 patients who dropped out or who were excluded
from the study did not differ with regard to sex, age or site
of onset of the disease from the 102 participants.
Characteristics of patients
Demographic and disease characteristics were collected
from the patients’ medical files. Stage of disease was
assessed using the revised ALS functional rating scale
(ALSFRS-r) [4]. The patients’ symptoms were measured
using a structured questionnaire based on the format
applied in a nationwide survey [23].
We examined how the patient coped using the Utrecht
Coping List (UCL) [21, 26]. The Mini Mental State
Examination (MMSE) was performed to test for severe
cognitive impairment [5].
End-of-life practices
The questions for the physicians on end-of-life practices
were based on the questionnaire of the nationwide survey
containing medical end-of-life practices [23]. In these
questions we avoided the terms ‘‘euthanasia’’, ‘‘physician-
assisted suicide’’ and ‘‘sedation’’, because their connota-
tions are too varied. Instead, we used wording that
describes more closely actual medical practice, permitting
us to classify the answers in the categories defined here.
Euthanasia was defined as the administration of drugs with
the explicit intention of ending the patient’s life, at the
patient’s explicit request. Physician-assisted suicide was
defined as the prescription or supplying of drugs with the
explicit intention of enabling the patient to end his or her
own life. Continuous deep sedation (CDS) was defined as
the administration of drugs to keep the patient in deep
sedation or coma until death.
If a physician reported more than one end-of-life prac-
tice, only the practice considered to have the greatest
potential to influence the hastening of a patient’s death was
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included in the analysis [23]. The practices in order of
decreasing influence were: (1) EAS, (2) withholding or
withdrawing medical treatment with the explicit intention
of hastening death, (3) intensified alleviation of pain or
symptoms while taking into account the possible hastening
of death, and (4) withholding or withdrawing medical
treatment while taking into account the possible hastening
of death. CDS was not categorized under end-of-life
practices, but was treated as a separate practice [23]. We
chose to categorize CDS differently from ‘‘the intensified
alleviation of pain or symptoms while taking into account
the possible hastening of death’’, because the explicit goal
of CDS is to remedy otherwise untreatable symptoms and
not to hasten death.
Symptoms of depression and quality of life
In end-stage patients with ALS, symptoms of a depression
according to the DSM-IV may overlap with symptoms of
ALS, which may result in an over-estimation of depression
[17]. We, therefore, used a short version of the Composite
International Diagnostic Interview (CIDI) and the Hospital
Anxiety and Depression Scale (HADS) which does not
include questions on somatic symptoms and which has also
been used in previous studies [1, 11]. A HADS symptom of
depression score of 11 or more is considered to be an
indication of a possible depression and an anxiety score of
10 or more as an indication of anxiety [8]. The CIDI is
positive for ‘depression’ if the patient had depressive
feelings or diminished interest or pleasure in all, or almost
all, activities most of the day, nearly every day for a
minimum of two consecutive weeks. Finally, depressive
symptoms were assessed by asking the patients: have you
felt depressed during the last 3 months [13]?
Quality of life was measured using the 40-item ALS
assessment questionnaire (ALSAQ-40) on a five-point
scale [14].
Characteristics of care
We used the patient version of the Palliative Outcome
Scale (POS) to assess quality of care characteristics [10].
All questions on received care, as shown in Online
Appendix Table 5, were assessed using a structured ques-
tionnaire based on a previous ALS study on quality of care
[29].
Statistical analysis
Chi-square test was used to analyze differences between
the patients who explicitly requested EAS and those who
did not. Fisher’s exact test was used when cells had an
expected frequency of less than five. For differences in
continuous variables, the Mann–Whitney U test was used
to calculate significance. The above analyses were also
performed for patients who actually died as a result of EAS
and those who did not. The 11 patients who suddenly died
unexpectedly were excluded from these analyses as they
were not able to opt for EAS [23].
All tests were two-sided, and a p value of less than 0.05
was considered to indicate statistical significance. Missing
values ranged from 0 to 10.
Results
Characteristics of patients
The characteristics of the 102 participants are presented in
Table 1. Thirty-two patients (31 %) explicitly approached
their physician with a request for EAS between one and
72 weeks prior to their death (median 9 weeks). There
were no significant differences in the stage of disease,
experienced symptoms or coping styles between patients
who explicitly requested EAS and those who did not.
End-of-life practices
Table 2 presents the end-of-life practices that were actually
performed, showing that 22 percent of the patients died as a
result of EAS. Ten percent died during continuous deep
sedation, which was in conjunction with ‘intensified alle-
viation of symptoms’ or ‘withholding medical treatment’ in
nine patients. One patient received artificial fluids and
nutrition during sedation. Only one of the ten patients who
died during continuous deep sedation had made an explicit
request for EAS.
Table 3 presents the outcome of the 32 patients who
explicitly approached their physician with a request for
EAS. Ten patients’ requests were not acted upon because
four patients died before EAS could be performed, four
died during the decision-making process, and two with-
drew their request.
Symptoms of depression and quality of life
No significant differences in the quality of life and
depressive symptoms were found between patients who
explicitly requested EAS and those who did not (Table 4).
About one in six patients fulfilled criteria for depression
according to the CIDI in both groups. Patients who scored
11 or more on the HADS depression subscale reported that
they felt less eager when looking forward to joyous events
than they had prior to becoming ill (100 %), and that they
felt (far) less happy about things they used to enjoy (96 %).
The majority within this group reported that they could
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Table 1 Patients’
characteristics
a A higher score on the ALS
functional rating scale
(ALSFRS-r) reflects a healthier
stage of disease
Variable median (range) Explicit request for EAS p value
No (n = 70) Yes (n = 32)
Demographic characteristics
Gender (%) 0.79
Female 37 34
Male 63 66
Place of death (%) 0.79
Nursing home or hospice 21 16
Hospital 17 10
Home 62 74
Disease characteristics
Site of onset (%) 0.45
Bulbar 36 28
Spinal 64 72
Age at onset (years) 61 (33–82) 62 (40–80) 0.66
Survival time (years) 2.8 (0.8–7.4) 2.8 (0.4–6.4) 0.82
Diagnosis (%)
Sporadic ALS 96 100 0.55
Familial ALS 4 0
Stage of disease
ALSFRS-ra 21 (4–45) 20 (7–36) 0.60
Symptoms in last 3 months of study (%)
Fatigue 85 77 0.35
Pain 38 39 0.93
Vomiting 7 7 1.0
Immobility 72 71 0.91
Dependency 85 90 0.75
No chance of improvement 64 74 0.32
Fear of choking 41 42 0.93
Feeling a burden on family 51 65 0.21
Suffering without improvement 36 42 0.58
Futile suffering 16 16 0.97
Loss of dignity 52 45 0.61
Table 2 End-of-life practices in 102 patients
End-of-life practices n (%)
Unexpected sudden death 11 (11)
No end-of-life practices 21 (20)
Total end-of-life practices performed 70 (69)
Euthanasia 21
Physician-assisted suicide 1
Ending of life without explicit request by patient 0
Intensified alleviation of symptoms 32
Withholding or withdrawing medical treatment 16
Continuous deep sedationa 10 (10)
Unexpected sudden death, no end-of-life practices and total end-of-
life practices performed add up to 100 %
a Continuous deep sedation has been provided in conjunction with
intensified alleviation of symptoms or withholding medical treatment;
patients are, therefore, also included in these categories
Table 3 Practices in 32 patients who explicitly requested euthanasia
or physician-assisted suicide
n
End-of-life practices performed
Euthanasia 21
Physician-assisted suicide 1
Intensified alleviation of symptoms, because
Patients went through the decision-making process but died
before euthanasia could be performed
4
Patient died during decision-making process 1
Withholding or withdrawing medical treatment, because
Patients withdrew request 2
Patient died during decision-making process 1
No end-of-life practice, because patients died during decision-
making process
2
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rarely appreciate a good book, TV- or radio show (70 %).
Patients who scored 10 or more on the HADS anxiety
subscale reported they frequently felt anxious (94 %) and
they panicked suddenly (94 %).
In total, 17 patients (1 in 6) thought of themselves as
being depressed; 10 of them were treated with antide-
pressants. Of the other seven, two patients had not yet
discussed their symptoms with a physician, two were
offered treatment but refused it, and two consulted a social
worker but did not wish to visit a psychologist. One patient
did not receive any treatment, but wished to consult a
psychologist or social worker. This patient did not
explicitly request EAS. Forty-seven percent of the patients
who thought of themselves as being depressed were also
classified as depressed according to the CIDI.
Characteristics of care
The care received from professional caregivers and the
available aids and appliances was usually reported as
adequate (Online Appendix Table 5). At the last mea-
surement prior to death, 84 % of all patients thought that
the health care in general was good or excellent (86 % of
patients with explicit EAS request, p = 0.30). One patient
within this group reported the care received to be very
poor. This was a 75-year-old, married woman, who lived in
a nursing home. She was not able to walk or speak, had
difficulties swallowing, was short of breath, and explicitly
requested EAS. While the physicians were still involved in
the decision-making process, she died of a myocardial
infarction. She received care from a rehabilitation physi-
cian, dietician, occupational therapist, social worker and
the nursing home caregivers. The patient scored 18 on the
HADS depression subscale, she did not receive antide-
pressants nor did she visit a psychologist, but she indicated
that she did not want to do so. Nor did she want artificial
administration of fluids and nutrients to compensate for her
swallowing difficulties.
Three other patients regarded the aids and appliances as
being very poor. The main source of dissatisfaction was
their wheelchair. They reported that they received the
wheelchairs too late and that they were not adequate. Two
of these three patients scored eleven or more on the HADS
depression subscale and one scored ten or more on the
HADS anxiety subscale, but none of them requested EAS.
Seventy-one percent of the patients were satisfied with
the frequency of the consultations of all professional
caregivers (Online Appendix Table 5). At the last visit
prior to death, patients had expressed a wish for more
frequent consultations from the primary care physician
(10 %), the rehabilitation physician (10 %) or more assis-
tance at home with personal care (11 %).
Performing EAS
The reported associations in Tables 1, 4 and 5 were also
calculated for the 21 patients who actually died as a result
of EAS and those who died without EAS (not shown). We
could not find a significant difference or trend between
these two groups in any of the quality of life or care items,
Table 4 Symptoms of depression and quality of life in 102 patients
Variable median (range) Explicit request for EAS p value
No (n = 70) Yes (n = 32)
Symptoms of depression
HADSa; total score 14 (1–42) 13 (1–28) 0.83
Anxiety score 5 (1–21) 6 (0–14) 0.90
Depression score 8 (1–21) 7 (1–20) 0.65
Anxiety score C10 % 19 13 0.45
Depression score C11 % 26 28 0.80
Depressed according to patient (%) 18 16 0.78
CIDIb; depression (%) 16 13 0.77
Quality of life
ALSAQ-40c; total score 106 (12–156) 103 (46–157) 0.87
Mental score 15 (0–36) 17 (0–37) 0.57
Physical score 91 (12–120) 89 (39–120) 0.79
a A higher HADS score reflects more symptoms of depression. A HADS symptoms of depression score of 11 or more is considered an indication
of a possible depression and an anxiety score of 10 or more as an indication of anxiety
b CIDI is positive for depression if the patient was depressed and/or had diminished interest or pleasure in all, or almost all activities most of the
day, nearly every day for a minimum of two consecutive weeks
c A higher ALSAQ-40 score reflects a lower quality of life
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symptoms of depression, coping style or characteristics of
the disease.
Discussion
The frequency of EAS is consistent with previous retro-
spective studies on EAS in patients with ALS in The
Netherlands, performed in the periods 1994–1999 and
2000–2005, and therefore, suggest a stable proportion of
EAS in this population even though ALS care in general
has improved during this period [24, 28, 32]. In 2005, the
national Dutch study on end-of-life practices showed that
the general EAS proportion decreased and that continuous
deep sedation increased, suggesting that continuous deep
sedation may be used as a substitute for EAS by physicians
[25, 31]. The findings of our prospective study do not
support continuous deep sedation being used as a substitute
for EAS in ALS, as only one of ten patients who died
during continuous deep sedation had explicitly requested
death to be hastened. According to the treating physician of
the patient who explicitly requested EAS, the sedation was
performed without appreciating the possibility of hastening
death.
In a recent, prospective survey on the attitudes towards
hastened death in Germany and Switzerland which inclu-
ded 66 ALS patients, half of the patients could imagine
asking for assisted suicide or euthanasia and 14 %
expressed a current wish to hasten death at baseline which
did not change at follow-up measurements. The wish to
hasten death was predicted by depression, anxiety, loneli-
ness, perceiving to be a burden to others, and a low quality
of life. A comparison with our results is difficult as, in
contrast to our study, the data could not be related to the
actual act of hastening death, a difference in use of the
HADS scoring system and because of the differences in the
legal system in different countries. This is reflected by their
finding that none of the patients talked to their physician
about their wish to hasten death; this would be unusual in
The Netherlands [27].
Our finding that patients who explicitly requested EAS
received the same care and were just as satisfied with their
care as patients who did not explicitly request EAS is in
accordance with a Belgian study. A large, retrospective
study of 1,690 non-sudden deaths in Belgium showed no
indication that EAS is performed more often among
patients who do not use multidisciplinary palliative care
services [30]. In our study, 84 % of all patients in end-stage
ALS reported that their health care in general was good or
excellent. This agrees well with the findings in the North
American ALS CARE project, which reported that 89 % of
the patients with ALS were satisfied with their medical
care. Most of these patients were, however, at an earlier
stage of the disease, having been diagnosed within the
previous 6 months [9].
As expected, the prevalence of depression according to
the CIDI was higher in our study than the average per-
centage of depression in the last 12 months in a general
population (6.6 %) [12]. We did not find an association
between depressive symptoms and EAS, which is in
accordance with a study on attitudes towards assisted sui-
cide in Oregon (USA) [8]. Our results contrast, however,
with another American study, in which patients with ALS
who expressed the wish to die were more likely to meet
criteria for depression [1]. Nevertheless, the authors of this
last study decided that caution is needed in concluding that
the desire to hasten dying in end-stage ALS is simply a
feature of depression, since depression in end-stage disease
is difficult to separate from existential suffering which
leads patients to question why they should continue to live.
Strengths of this study are the longitudinal, prospective
design, the high response rates, the decreased chance of
socially acceptable answers to questions due to the open
culture towards EAS in The Netherlands, and the avail-
ability of information on actually performed EAS instead
of the often-used wish to hasten death. A limitation of our
study is that we did not identify a possible clinical
depression with the help of a psychiatrist or psychologist.
Another limitation was that five patients were included in
this study and also in our previous retrospective study of
2000–2005 [15]. We believe that the impact of this overlap
is small when analyzing changes in EAS in time. Espe-
cially as none of these five patients requested EAS or
received EAS. Another limitation is that, although we were
able to include a relatively large number of end-stage ALS
patients in this prospective study, the number of patients
who explicitly requested EAS or who died as a result of
EAS limits the statistical power to detect determinants of
EAS.
However, the results on care received, symptoms of
depression and quality of life of patients who explicitly
requested EAS and those who did not, do not show any
trend towards a consistent association.
A relatively high number of patients with ALS explicitly
ask their physician for EAS and receive EAS. Our study
does not support the notion that unmet palliative care needs
are related to EAS. Further research on determinants of
EAS may focus more on intrinsic values, psychological and
social factors; 84 % of all patients reported that their health
care in general was good or excellent. Nevertheless,
although not related to EAS, our study shows that there are
shortcomings in the provision of care. For example, the
considerable percentage of patients who fear choking
([40 %) contrasts sharply with the actual frequency of
choking in the end stage of ALS and with our finding that
death is considered to be peaceful in more than 94 % of
J Neurol (2014) 261:1894–1901 1899
123
ALS patients in The Netherlands [15]. This emphasizes the
need for adequate and timely patient information regarding
symptoms and palliative care in the final stage of the
disease.
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